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Summary
 
Jak3 mediates growth signals through cytokine receptors such as interleukin-2 (IL-2), IL-4, and
IL-7, and its deficiency results in autosomal recessive SCID in mice and humans. In spite of
the severely reduced number of lymphocytes in Jak3-deficient mice, the differentiation profile
of thymocytes was normal and mature T cells accumulated in the periphery with age. How-
ever, we found that self-reactive T cells were not deleted in the thymus and the peripheral tis-
sues in Jak3-deficient mice. All peripheral T cells were in the activation state and thus were un-
 
able to be activated further, as demonstrated by the failure of eliciting Ca
 
2
 
1
 
 response upon T
cell receptor (TCR) stimulation. From the analysis of TCR-transgenic Jak3-deficient mice,
only self-reactive T cells appeared to be in the activated state and anergic. These findings dem-
onstrate a crucial function of Jak3 in the negative selection of autoreactive T cells and the
maintenance of functional peripheral T cells.
 
J
 
ak3 is associated constitutively with the common 
 
g
 
 chain
(
 
g
 
c
 
), a subunit of the cytokine receptors of IL-2, IL-4,
IL-7, IL-9, and IL-15, and has been shown in vitro to be
essential for their signal transduction (1–8). In the case of
IL-2 signaling, Jak3 is activated as one of the earliest events
upon IL-2 binding to IL-2 receptor (2, 8–9), and then acti-
vates Stat5 to translocate into the nucleus for mediating
growth signals. In addition, the constitutive activation of
the Jak3–Stat5 signaling pathway causes IL-2-independent
growth for HTLV-1-transformed T cells (10). These in
vitro analyses have demonstrated that the signal through
Jak3 is essential for and regulates cell growth of lympho-
cytes.
SCID is a disease based on several different genetic ab-
normalities, one of them being X-linked SCID (XSCID)
caused by functional mutations of the 
 
g
 
c
 
 (11). It has re-
cently been shown that Jak3 deficiency caused autosomal
recessive SCID (AR-SCID) in humans, with symptoms
similar to XSCID (12–13). Recently, we and others estab-
lished Jak3-deficient mice (
 
Jak3
 
2
 
/
 
2
 
) as an animal model of
human AR-SCID (14–16). 
 
Jak3
 
2
 
/
 
2
 
 mice revealed severe
developmental inhibition of B cells, NK cells, and 
 
gd
 
 T cells
in the skin and small intestine. These results demonstrated the
important roles of Jak3 in the development of lymphocytes
and NK cells in vivo. Although thymocytes and peripheral
T cells were drastically reduced in young Jak3-deficient
mice, T cells gradually accumulated in the peripheral organs
with age in the absence of functional growth signals medi-
ated by Jak3. We analyzed the repertoire and function of
these thymocytes and peripheral T cells in 
 
Jak3
 
2
 
/
 
2
 
 mice
and found defects of negative selection of self-reactive T cells
in the thymus and the periphery, demonstrating a novel
function of Jak3 in mediating negative selection and in
maintaining functional T cells.
 
Materials and Methods
 
Mice.
 
C57BL/6 mice were purchased from Japan SLC, Inc.
(Hamamatsu, Japan). DO11.10 TCR-transgenic mice (DO-Tg)
were provided by Dr. D. Loh (Nippon Roche Research Center,
Kamakura, Japan) (17). Jak3-deficient mice were previously de-
scribed (15).
 
Analysis of Cell Proliferation and IL-2 Secretion.
 
For proliferation
assay, splenocytes (2 
 
3
 
 10
 
5
 
) from 8-wk-old mice were stimulated
with Con A (2.5 
 
m
 
g/ml), PMA (5 ng/ml) plus A23187 (100 ng/
ml), and anti-CD3
 
e
 
 mAb (145-2C11) cross-linking for 48 h,
pulsed with 37 kBq [
 
3
 
H]thymidine (Amersham Corp., Arlington
Heights, IL) for the last 8 h of culture, and harvested. [
 
3
 
H]thymi-
dine uptake was measured with a MicroBeta
 
Ô
 
 liquid scintillation
counter (Pharmacia, Uppsala, Sweden). For IL-2 production, pro-
liferation of the IL-2-dependent cell line CTLL-2 was measured.
CTLL-2 cells (6 
 
3
 
 10
 
3
 
) were cultured with supernatants from the
proliferation assay after stimulation for 48 h. Cells were pulsed
with [
 
3
 
H]thymidine and harvested as described above.
 
Measurement of Intracellular Ca
 
2
 
1
 
 Response. 
 
Intracellular Ca
 
2
 
1
 
mobilization was measured using Epics Elite ER-3 (Coulter
Corp., Hialeah, FL) with a Cell Quest analyzing program. 2 
 
3
 
10
 
7
 
 cells were incubated with 4 
 
m
 
M Indo-1 (Molecular Probes,
Inc., Eugene, OR) for 30 min at 37
 
8
 
C for loading. For TCR
stimulation, cells were incubated with anti-CD3
 
e
 
 mAb (145-
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2C11) for 30 min on ice and washed. After measuring the basal
level, 10 
 
m
 
g goat anti–hamster Ig was added for cross-linking. For
the response by Ca
 
2
 
1
 
 ionophore, 1 
 
m
 
g A23187 (Sigma) was
added after measurement of the basal level.
 
Flow Cytometric Analysis.
 
Splenocytes and lymph node T cells
were incubated with fluorescence- or biotin-conjugated antibod-
ies and analyzed with a FACScan
 
Ò
 
 (Becton Dickinson, Mountain
View, CA) using Cell Quest software. 5 
 
3
 
 10
 
5
 
 cells were analyzed
for each sample. For multicolor analysis, cells were first incubated
with anti-FcR
 
g
 
 receptor mAb 2.4G2 to prevent nonspecific stain-
ing. The following antibodies were used: CD4 (RM4-4), CD8
 
a
 
(53-6.7), CD69 (H1.2F3), CD44 (1M7), CD25 (7D4), and MEL-
14. These Abs, as well as all anti-V
 
b
 
 mAbs (V
 
b
 
2–V
 
b
 
14), were pur-
chased from PharMingen (San Diego, CA). Anti-clonotypic mAb
against DO11.10 TCR, KJ1-26, was provided by Dr. P. Marrack
(Denver, CO).
 
Results
 
Failure of Deletion of Self-reactive T Cells in the Thymus and
Periphery of Jak3-deficient Mice.
 
When the V
 
b
 
 repertoire of
splenic T cells from Jak3-deficient mice with C57BL/6
background was analyzed, there was no difference in the
frequency of V
 
b
 
 usage between 
 
Jak3
 
2
 
/
 
2
 
 mice and wild-
type littermates (data not shown). To analyze the repertoire
of T cells reactive to endogenous MMTV products pre-
sented on I-E molecule, we backcrossed with BALB/c and
analyzed the V
 
b
 
 usage. As shown in Fig. 1 
 
A
 
, the fre-
quency of mature T cells expressing V
 
b
 
5 and V
 
b
 
11, but
not others, was significantly increased in 
 
Jak3
 
2
 
/
 
2
 
 mice as
compared with heterozygous mice. These V
 
b
 
-expressing
T cells are known to be deleted in BALB/c mice, whereas
C57BL/6 mice fail to delete them due to the lack of MHC
class II I-E molecules. Although extensive analysis could
not be performed on thymocytes due to their limited num-
ber in 
 
Jak3
 
2
 
/
 
2
 
 mice, similar increases of CD4 single-posi-
tive thymocytes expressing V
 
b
 
5 and V
 
b
 
11 were observed
(Fig. 1 
 
B
 
). It is noteworthy that, while the percentage of
V
 
b
 
11
 
1
 
 T cells in 
 
Jak3
 
2
 
/
 
2
 
 mice with H-2
 
d
 
 background was
almost restored to the level of C57BL/6 mice, the fre-
quency of V
 
b
 
5 was only partly recovered. These data demon-
strate that Jak3-deficient mice failed to delete self-reactive
T cells. Furthermore, the observation that the percentage
of V
 
b
 
10
 
1
 
 T cells was reduced in 
 
Jak3
 
2
 
/
 
2
 
 mice suggests ad-
ditional defects.
 
Peripheral T Cells in Jak3-deficient Mice Are Preactivated.
 
In addition to the existence of autoreactive T cells in thy-
mus, spleen, and lymph node, all peripheral T cells from
 
Jak3
 
2
 
/
 
2
 
 mice were activated as determined by surface ex-
pression of several markers. These T cells expressed high
levels of CD44 and CD69 (18–20) and a low level of Mel-
14, representing the phenotype of activated T cells (Fig. 2 
 
A
 
).
To analyze further the origin of the preactivated T cells
in the periphery of 
 
Jak3
 
2
 
/
 
2
 
 mice, we crossed 
 
Jak3
 
2
 
/
 
2
 
 mice
with OVA-specific DO-Tg mice whose TCR (DO-TCR)
was detected by staining with anti-clonotypic mAb KJ1-26
for the TCR
 
ab
 
 dimer and anti-V
 
b
 
8 mAb F23.1 for the
TCR
 
b
 
 chain. 
 
z
 
20% of the T cells from DO-Tg mice ex-
pressed endogenous TCR, but the rest of the cells were
Figure 1. Vb repertoire of T cells in the thymus and periphery of Jak3-
deficient mice. (A) Vb repertoire of CD41 peripheral T cells from Jak3-
homozygous (2/2) and heterozygous (1/2) mice. The percentages of T
cells expressing representative Vbs among CD41 T cells were shown as
the average 6 SD of three experiments. (B) Expression of Vb5 and Vb11
on CD41 CD82 thymocytes from Jak3-homozygous (2/2) and het-
erozygous (1/2) mice. Staining profiles with anti-Vb5 and anti-Vb11
mAbs (solid line) and control mAb (dotted line) on CD41CD82 thy-
mocytes. The percentages of Vb5- and Vb11-expressing T cells among
CD41CD82 thymocytes were indicated in each panel. For both (A) and
(B), thymocytes or B cell–depleted splenocytes were incubated first with
each anti-Vb mAb and then with a mixture of biotin-coupled goat anti–
mouse Ig and rat Ig Abs. After blocking with mouse and rat Ig, the cells
were stained with FITC–anti-CD4 and PE–anti-CD8 and streptavidin–
Quantum Red.353 Saijo et al. Brief Definitive Report
stained with KJ1-26 and F23.1 (17). Whereas KJ1-26 posi-
tive and negative populations from DO-Tg mice did not
show a significant difference in CD44 expression, the DO-
TCR-expressing (KJ1-26high) T cells from DO-Tg?Jak32/2
mice were CD44low (Fig. 2 B). In contrast, most of the T cells
expressing endogenous TCR (KJ1-26low) were CD44high,
which is the same phenotype as Jak32/2 splenic T cells
(Fig. 2 B). This was also shown by Mel-14 expression.
Whereas DO-TCR expressing T cells (Vb8high) were com-
posed of both Mel-14high and Mel-14low populations, T cells
expressing endogenous TCR (Vb8low) were all Mel-14low
(Fig. 2 B). These data demonstrate that T cells with endog-
enous TCR but not DO-TCR-expressing T cells were re-
activated in DO-Tg?Jak32/2 mice, suggesting that splenic
T cells in Jak32/2 mice may be autoreactive and have been
activated with self-antigens.
Defects of TCR Signaling in Peripheral T Cells from Jak3-
deficient Mice. Since splenic T cells in Jak32/2 mice are in
the activated state, we asked whether these T cells might
be functionally unresponsive to further stimulation. Indeed,
splenic T cells from Jak32/2 mice failed to proliferate upon
stimulation with either Con A or anti-CD3e mAb cross-
linking, regardless of the presence of exogenous IL-2.
Furthermore, these T cells did not proliferate even after
stimulation with PMA and Ca21 ionophore (Fig. 3 A). In
contrast with the splenic T cells, thymocytes from Jak32/2
Figure 2. Expression of acti-
vation markers on splenic T cells
from Jak3-deficient mice (A) and
DO-Tg?Jak32/2 mice (B). (A)
Staining profiles of CD69,
CD44, and Mel-14 on splenic T
cells from Jak3-deficient mice
(2/2) and wild-type littermates
(1/1). Cells were stained for ei-
ther CD69, CD44, or Mel-14 in
addition to CD4 and CD8, and
the profiles were shown for
CD41 T cells. The profiles for
CD81 T cells were almost the
same as for CD41 T cells. Thick
and thin lines indicated staining
with each Ab and control stain-
ing, respectively. (B) Expression
of CD44 (left) and Mel-14 (right)
on CD41 splenic T cells from
DO-Tg (1/1) and DO-
Tg?Jak32/2 ( 2 / 2 ) mice. (Top
left) Staining profiles with the
clonotypic mAb KJ1-26; cells
were divided into two groups,
KJ1-26 high and low. (Bottom
left) Thin and thick lines indicate
CD44 staining for KJ1-26 high
and low cells, respectively. (Top
right) Staining profiles with anti-
Vb8 mAb; cells were divided
into two groups, Vb8 high and
low. (Bottom right) Thin and
thick lines indicate Mel-14 stain-
ing for Vb8 high and low cells,
respectively.354 Requirement of Jak3 for Negative Selection
mice responded to both anti-CD3e cross-linking and stim-
ulation with PMA plus Ca21 ionophore (15). As shown in
Fig. 3 B, thymocytes from Jak32/2 mice secreted a consid-
erable amount of IL-2 compared with normal thymocytes,
while splenic T cells from Jak32/2 mice produced very lit-
tle. Cell surface staining revealed no difference in TCR ex-
pression between Jak32/2 and wild-type mice (15). These
data demonstrated that splenic T cells in Jak32/2 mice pos-
sess defects in the signal transduction pathway leading to
IL-2 production upon TCR stimulation, in addition to
growth signal defects.
To investigate the defects in TCR activation, we ana-
lyzed intracellular Ca21 mobilization as an indicator of the
early signal transduction pathway upon TCR stimulation.
As shown in Fig. 4 A, thymocytes from Jak32/2 mice elic-
ited almost comparable Ca21 response to that of thy-
mocytes from wild-type mice upon stimulation with both
anti-CD3e mAb cross-linking and Ca21 ionophore. In
Figure 3. Functional analysis
of thymocytes and splenic T cells
from Jak3-deficient mice. (A)
Proliferation of splenic T cells
upon mitogenic stimulation.
Splenocytes (2 3 105) from Jak3
homozygous (2/2), heterozy-
gous (1/2) mutant mice, and
wild-type littermates (1/1)
were stimulated with anti-CD3e
mAb (145-2C11, 10 mg/ml),
Con A (2.5 mg/ml), IL-2 (40 U/
ml), Staphyloccocal enterotoxin
B (10 mg/ml), and the combina-
tion of PMA (5 ng/ml) and
A23187 (100 ng/ml). Cells were
cultured for 48 h and pulsed
with [3H]thymidine for 8 h. (B)
IL-2 production of thymocytes
and splenic T cells upon mito-
genic stimulation. Thymocytes
and splenic T cells from Jak3-
homozygous (2/2), and het-
erozygous (1/2) mutant mice,
and wild-type littermates (1/1)
were stimulated with 145-2C11,
Con A, and PMA plus A23187
as described in (A). All results
were presented as mean 6 SD
from triplicate cultures.355 Saijo et al. Brief Definitive Report
contrast, splenic T cells from Jak32/2 mice failed to elicit
Ca21 response upon TCR cross-linking in spite of the fact
that these cells showed Ca21 flux upon stimulation with
Ca21 ionophore (Fig. 4 B). These data clearly demonstrate
that splenic T cells from Jak32/2 mice have defects in early
Ca21 signaling upon activation through the TCR complex.
Discussion
Mutations in gc and Jak3 in the patients of XSCID (11)
and AR-SCID (12–13), respectively, caused growth defects
in T cells because gc and Jak3 are associated (2, 8) and are
both required for growth signal in T cells (9). The failure of
cell growth has been thought to be due to defective cyto-
kine receptor signaling. In the present study, we have dem-
onstrated that, in addition to the growth defects, AR-SCID
model mice have defects in negative selection of self-reac-
tive T cells. Thus, Jak3-deficient mice possess forbidden auto-
reactive T cells in the thymus and periphery. The reason
these mice do not develop autoimmune diseases may be be-
cause these autoreactive T cells are anergic to further stim-
ulation. Although Jak3 deficiency resulted in a dramatic de-
crease in the number of precursor cells in the thymus, once
they were seeded in the thymus, thymocyte differentiation
appeared to take place normally (15). However, we found
that Jak3 deficiency resulted in a failure to eliminate self-reac-
tive thymocytes, consequently leading to the accumulation
of autoreactive but anergic peripheral T cells.
How Jak3 is involved in negative selection is unknown
at present. One possibility is that Jak3-mediated growth
signal is crucial for the subsequent deletion of self-reactive
thymocytes in addition to signals through TCR. The other
intriguing possibility is that Jak3 is directly involved in T cell
activation. Our observation that PMA plus Ca21 ionophore
did not stimulate IL-2 production in splenic T cells from
Jak32/2 mice, as well as the previous finding that Jak3 is
crucial for preventing the induction of anergy in T cells
(21), are consistent with this idea.
Signaling defects in splenic T cells from Jak32/2 mice
were observed in association with reactivated status, namely
the high expression of activation markers such as CD44
and CD69 as well as the downregulation of Mel-14.
Splenic T cells were reactivated in Jak3-deficient mice and
were all refractory to further activation. From the analysis
of DO-Tg?Jak32/2 mice, we showed that the appearance
of reactivated and refractory T cells depended on the speci-
ficity of TCR. Because thymocytes from Jak3-deficient mice
do not exhibit the activated phenotype and proliferate, se-
crete IL-2 and exhibit Ca21 flux upon TCR stimulation,
preactivation of splenic T cells probably takes place during
immigration after leaving the thymus or within the periph-
ery. Considering that only T cells with endogenous TCRs
exhibited the activated phenotype, it is likely that these T cells
were activated with self-peptides in the periphery, while
OVA-specific T cells could not be activated in the absence
of OVA peptide. The fact that defects in negative selection
were influenced by TCR specificity is consistent with our
observation that some Vb1 T cells were completely re-
stored from deletion, while some others were only partly
recovered by Jak3 deficiency (Fig. 1). Such autoreactive
T cells are in an anergic state after activation. Alternatively,
provided that all T cells had been activated during immi-
gration from thymus to the periphery and then returned to
the resting state, T cells may fail to return in the absence of
Jak3, although some of them can still return to the resting
state depending on their TCR specificity. In either case,
Jak3 plays a pivotal role in maintaining the normal pheno-
type and function of peripheral T cells.
Further analysis will be required to elucidate the molec-
ular basis of defects of thymic negative selection and signal-
ing in peripheral lymphocytes from Jak3-deficient mice.
Figure 4. Intracellular Ca21 mobilization of thymocytes (A) and splenic
T cells (B) from Jak3-deficient mice (2/2) and wild-type littermates (1/1).
Thymocytes and splenocytes were stained with anti-CD4 and anti-CD8
mAbs, loaded with Indo-1, stimulated with cross-linking with 2C11 or
A23187 (Iono.), and then Ca21 responses were measured. Data for CD41
cells were represented. In both A and B, the peak (thick line) and sustained
line (dotted line) Ca21 responses were shown.356 Requirement of Jak3 for Negative Selection
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